<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04981249</url>
  </required_header>
  <id_info>
    <org_study_id>CIR 2020/023</org_study_id>
    <nct_id>NCT04981249</nct_id>
  </id_info>
  <brief_title>Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection</brief_title>
  <acronym>Mrisk-COVID</acronym>
  <official_title>Risk of Severe COVID-19, Taking Into Account Multimorbidity Patterns, as Well as Other Clinical and Sociodemographic Variables. Big Data Mrisk-COVID Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agència de Qualitat i Avaluació Sanitàries</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Aragones de Ciencias de la Salud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to analyze the patterns of chronic multimorbidity of a cohort of&#xD;
      Covid-19 patients, and to assess the relation between the patterns and the development of&#xD;
      severe infection or mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Big Data study that aims to establish the multimorbidity (MM) clusters of a cohort&#xD;
      of Covid-19 patients, and assess their potential relation with severe infection or mortality.&#xD;
      Databases of demographic information and complete medical records from the cohort will be&#xD;
      provided by the Agency for Health Quality and Assessment of Catalonia (AQuAS). Data will be&#xD;
      collected and integrated in a complete database in order to define the study variables:&#xD;
      multimorbidity patterns, COVID-19 severe infection and COVID-19 associated mortality. The&#xD;
      population will be stratified by sex and age (21-45, 46-65, 66-80 and 81-95 years). Diagnoses&#xD;
      from primary care and hospitals will be filtered and classified using the Chronic Condition&#xD;
      Indicator v.2021 and the Clinical Classification Software v.2021 [1], in order to identify&#xD;
      the Chronic Conditions (CC) of the patients. CC with prevalence &gt;2% in each age-sex strata&#xD;
      will be subjected to a fuzzy c-means clustering analysis. The final number of clusters in&#xD;
      each age-sex group will be determined under the clinical criteria of the research group&#xD;
      members. Percentages of patients that suffered severe Covid-19 infection or death in each&#xD;
      cluster will be calculated. Bivariate statistical analysis comparing the demographic data and&#xD;
      the cluster distribution with severe infection and mortality will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Covid-19 severe infection</measure>
    <time_frame>From 27-February-2020 to 15-June-2020</time_frame>
    <description>Severe COVID-19 infection was defined as the occurrence of at least one of the following conditions during any of the registered COVID-19 episodes: severe respiratory affection (including insufficiency, failure, or distress); use of respiratory support (including mechanical ventilation or oxygen therapy); septic shock; multiple organ failure (the combination of respiratory failure and any other organ failure); inflammatory response; admission to intensive care unit; and mortality.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Covid-19 mortality</measure>
    <time_frame>From 27-February-2020 to 15-June-2020</time_frame>
    <description>Death associated to COVID-19 infection episode</description>
  </primary_outcome>
  <enrollment type="Actual">14286</enrollment>
  <condition>Covid-19</condition>
  <condition>Chronic Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Confirmed or suspected Covid-19 patients from the first wave of the pandemic, aged &gt;20&#xD;
        years, residing in a healthcare region of about 400.000 inhabitants in a Northeast region&#xD;
        of Spain (Vallès Occidental Est, Catalonia, Spain).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Positive results of Covid-19 laboratory tests&#xD;
&#xD;
          -  Covid-19 related clinical profile verified by healthcare professionals&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male &gt;90 years&#xD;
&#xD;
          -  Females &gt;95 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Corporacio Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://www.hcup-us.ahrq.gov/home.jsp</url>
    <description>Agency for Healthcare Research and Quality. Rockville. MD. Healthcare Cost and Utilization Project (HCUP)</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Marisa Baré, MD, MPH, PhD</investigator_full_name>
    <investigator_title>Coordinator</investigator_title>
  </responsible_party>
  <keyword>Multimorbidity</keyword>
  <keyword>Cluster analysis</keyword>
  <keyword>Covid-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

